Should You Buy This Canadian Health Tech Stock-WELL.TO

Acrobull Canada Advisory Inc.

May 26			2025
Name	Ticker	Sector/Industry		Market Cap	Risk Factor
Well Health Technologies Corp.	WELL.TO-TSX	Healthcare- Medical Care		$1.023 Billion	Medium

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets.

Recent Highlights

WELL Health Enters into Automatic Share Purchase Plan- Well Health a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announced today that it has entered into an automatic share purchase plan (“ASPP“) with a broker in order to facilitate repurchases of the Company’s common shares (“Common Shares“) under its previously announced normal course issuer bid (“NCIB“).

WELL previously announced that it had received approval from the Toronto Stock Exchange (“TSX“) to, during the 12-month period commencing May 20, 2025 and terminating May 19, 2026, purchase up to 6,326,417 Common Shares, representing approximately 2.5% of the 253,056,708 Common Shares issued and outstanding as of May 7, 2025, by way of a NCIB on the TSX or through Canadian alternative trading systems or by such other means as may be permitted under applicable law.

First Quarter 2025 Highlights

WELL recorded a record quarterly revenue of $294.1 million in Q1-2025, up 32%(2) from Q1-2024, owing to organic growth and acquisitions. Circle Medical's revenue was reduced by a net of $6.5 million due to a delay in revenue recognition. Aside from this impact, quarterly sales was $300.7 million.

WELL achieved Adjusted EBITDA(1) of $27.6 million in Q1-2025, up 36%(2) from Q1-2024. This amount was impacted by a net loss of $6.5 million due to Circle Medical's delayed revenue recognition. Aside from this impact, quarterly Adjusted EBITDA was $34.1 million.

WELL received 1.6 million patient visits in Q1-2025, a 23% increase over Q1-2024, owing to the rise of Canadian patient services visits, which increased by 29% year on year, with strong organic growth of 13% in Canada.

WELL Canada, which includes our Canadian Clinics, WELLSTAR, and CYBERWELL businesses, increased Four Wall Adjusted EBITDA(1) by 29% YoY to a record $18.7 million in Q1-2025.

Stock Observation- The company has reported good financial results in the first quarter and the company has very good fundamentals and is expected to produce better results in the next financial quarter. The RSI level for the stock is at 33 which shows oversold conditions.

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

Considering all the factors and financials of the company Acrobull Canada Advisory Inc. maintains Customer Choose Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull Canada Advisory Inc. only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull Canada Advisory Inc. would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull Canada Advisory Inc. is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull Canada Advisory Inc. does not guarantee returns.

Acrobull Recommendation Based on Evaluation

Current Market Price	$4.04 CAD
Acrobull Recommendation	Buy
Target Price	$4.55 CAD
RSI Level	14 Day RSI 42
Total Shares Outstanding	253.13 Million
Shares held by Insiders Risk Factor Stop Loss	20.99% Medium 5%